MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TAIRA, Y.
Right arrow Articles by BARON, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TAIRA, Y.
Right arrow Articles by BARON, J.

Molecular Pharmacology, Vol 18, 304-312, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Effects of Phenobarbital, Pregnenolone-16agr-Carbonitrile, and 3-Methyicholanthrene Pretreatments on the Distribution of NADPH-Cytochrome c(P-450) Reductase within the Liver Lobule

YOSHITSUGI TAIRA 1, PHILLIP GREENSPAN 1, GORDON F. KAPKE 1, JAN A. REDICK 1, and JEFFREY BARON 1

1 The Toxicology Center, Department of Pharmacology, College of Medicine, The University of Iowa, Iowa City, Iowa 52242

The effects of phenobarbital, pregnenolone-16agr-carbonitrile, and 3-methylcholanthrene pretreatments on the distribution of NADPH-cytochrome c (P-450) reductase (NADPH: ferricytochrome oxidoreductase, EC 1.6.2.4) within the livers of male rats were investigated employing sheep antiserum produced against rat hepatic microsomal NADPH-cytochrome c reductase in indirect fluorescent antibody and unlabeled antibody peroxidase-antiperoxidase immunohistochemical staining techniques. In the livers of untreated and vehicle-pretreated rats, the extent of binding of the antireductase to hepatocytes was found to be similar within the centrilobular and midzonal regions of the lobule but significantly lower within the periportal regions of the lobule. Pretreatment of rats for 4 days with 3-methylcholanthrene did not result in alterations in either the pattern or the intensity of immunohistochemical staining for the reductase within the liver lobule. In the livers of rats which had been pretreated for 4 days with phenobarbital, microfluorometric analyses revealed a twofold increase in the extent of antireductase binding to hepatocytes within all regions of the lobule. In contrast to the effects of phenobarbital, pregnenolone-16agr-carbonitrile markedly altered the pattern as well as the intensity of immunohistochemical staining for NADPH-cytochrome c (P-450) reductase within the liver lobule. After 4 days of pregnenolone-16agr-carbonitrile pretreatment, there was a threefold increase in the extent of antireductase binding to hepatocytes within the periportal regions of the lobule, while the extent of antireductase binding to centrilobular and midzonal hepatocytes was increased by only 73 and 45%, respectively. Thus, in the livers of pregnenolone-16agr-carbonitrile-pretreated rats, the antireductase bound to a similar extent to periportal and midzonal hepatocytes and to a significantly greater extent to centrilobular hepatocytes. These results demonstrate that, although both phenobarbital and pregnenolone-16agr-carbonitrile induce NADPH-cytochrome c (P-450) reductase in hepatocytes throughout the liver lobule, phenobarbital appears to produce a uniform induction of the reductase within the lobule, while pregnenolone-16agr-carbonitrile induces the reductase by significantly different extents within the three lobular regions.

Submitted on February 11, 1980
Accepted on May 6, 1980




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
E. Hazai and D. Kupfer
INTERACTIONS BETWEEN CYP2C9 AND CYP2C19 IN RECONSTITUTED BINARY SYSTEMS INFLUENCE THEIR CATALYTIC ACTIVITY: POSSIBLE RATIONALE FOR THE INABILITY OF CYP2C19 TO CATALYZE METHOXYCHLOR DEMETHYLATION IN HUMAN LIVER MICROSOMES
Drug Metab. Dispos., January 1, 2005; 33(1): 157 - 164.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics